Vaccinations are a controversial topic, and there have been innumerable studies on the efficacy of them since they were first formulated. Although they would not be available for administration if the potential benefits did not outweigh the risks, there are still individuals who can engage in heated debates on their perception of the overwhelming cons of vaccinations. The pneumococcal vaccination is of particular importance to older individuals.
Older adults are more likely to have comorbid conditions that impact their ability to recover from various acute illnesses. With an emphasis on preventative medicine and attempting to prevent costly hospitalizations, resources are being geared towards various approaches aimed at keeping individuals in an optimal state of health at home. The average length of stay for community-acquired pneumonia hospitalizations is 5.2 days, and the median cost for the aforementioned hospitalization is $7,282 (Olasupo, Xiao, & Brown, 2018). Not only are patients experiencing a financially burdensome time with hospitalization, but after over 5 days in the hospital, they still experience downtime where they are unable to return to their former level of functioning, if they are ever able to recover. Therefore, it is recommended for the correlation between pneumococcal vaccination status and hospitalization for community-acquired pneumonia to be studied and established to effectively disseminate data regarding one’s increased or decreased likelihood to be hospitalized for community-acquired pneumonia if he or she receives the pneumococcal vaccination.
Date of publication
MSN Capstone Project (Local Access)
Masters of Science in Nursing
Terry, Lauren, "Pneumococcal Vaccination Benchmark Project" (2020). MSN Capstone Projects. Paper 30.